3B BlackBio Dx's Coris BioConcept Acquires Bilex SRL to Own Manufacturing Facility, Generating €140,000 Annual Savings
Acquisition of 100% shares finalized on November 18, 2026, securing property in Belgium's Créalys® Science Park and consolidating operations
3B BlackBio Dx Limited's subsidiary, Coris BioConcept SRL, announced the acquisition of 100% shares of Bilex SRL, owner of its manufacturing plant and office building in Gembloux, Belgium, for €274,817. This transition from tenant to owner aims to eliminate intercompany rental payments and generate annual savings of €140,000 before depreciation, enhancing infrastructure control without additional regulatory approvals.
3B BlackBio Dx Limited
Acquisition / Amalgamation / Merger / Demerger
Coris BioConcept SRL, a subsidiary of 3B BlackBio Dx Limited, acquired 100% ownership of Bilex SRL, the entity that owns the land and building of Coris's manufacturing plant and office in Gembloux, Belgium, for €274,817. This acquisition, completed on November 18, 2026, transitions Coris from tenant to owner, eliminating rental payments and generating annual savings.
Bilex SRL owns the facility located at 11, Rue Guillaume Fouquet, Gembloux, Belgium, including a modern building with laboratories and offices on a 6,443 m² land parcel.
The building, constructed in 2023, includes energy-efficient features such as 256 solar panels and large rainwater collection tanks supporting environmental sustainability.
The acquisition involved payment of €274,817 for shares, €1.32 million to cover unsecured loans to shareholders, and continuation of €2.11 million in long-term building loans at 1.3% average interest payable over 12 years.
The transition to ownership is expected to immediately save €140,000 annually before depreciation by removing rental costs, leaving only interest expenses and depreciation on the balance sheet.
Bilex SRL will become a wholly owned subsidiary of Coris BioConcept, supporting its global diagnostic pipeline with secure infrastructure and investment stability.
Highlights
- Acquisition date: November 18, 2026
- Acquisition cost: €274,817 plus €1.32 million unsecured loan repayment and €2.11 million building loans
- Annual savings estimated at €140,000 before depreciation
- Facility located in Créalys® Science Park, Gembloux, Belgium
- Bilex SRL becomes a wholly owned subsidiary of Coris BioConcept
Key Data Snapshot
What happened
- Coris BioConcept SRL acquired 100% shares of Bilex SRL, the owner of its Belgium manufacturing facility, becoming owner-occupier.
- Acquisition was finalized on November 18, 2026, transitioning from tenant to owner and eliminating intercompany rental payments.
- The transaction involved cash payment, loan repayment, and assumption of long-term building financing.
Key details
- The purchased building is located in Créalys® Science Park, Gembloux, built in 2023 with advanced labs and offices.
- Facility includes environmental features such as solar panels and rainwater collection tanks.
- Annual net savings of €140,000 before depreciation expected due to elimination of rental payments.
- The long-term building loan of €2.11 million continues with low-interest rate of 1.3% for 12 years.
- Bilex SRL will operate as a wholly owned subsidiary of Coris BioConcept post acquisition.
Background and context
- Bilex SRL was incorporated in 2014 and owns the land and building housing Coris BioConcept's operations in Belgium.
- Coris BioConcept is a subsidiary of 3B BlackBio Dx Limited, specializing in rapid diagnostic kits for antimicrobial resistance.
- The acquisition aligns with Coris BioConcept’s goal for long-term cost optimization and securing permanent infrastructure support.
Highlights
- Acquisition date: November 18, 2026
- Acquisition cost: €274,817 plus €1.32 million unsecured loan repayment and €2.11 million building loans
- Annual savings estimated at €140,000 before depreciation
- Facility located in Créalys® Science Park, Gembloux, Belgium
- Bilex SRL becomes a wholly owned subsidiary of Coris BioConcept
Disclosures
- SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
The acquisition does not fall within related party transactions; promoters have no interest in Bilex SRL.
None
More News on Acquisition / Amalgamation / Merger / Demerger
View allLatest corporate announcements and market updates in Acquisition / Amalgamation / Merger / Demerger.
FIH Mauritius Investments Ltd Acquires 3.24% Additional Stake in IIFL Capital Services, Becoming Promoter
FIH Mauritius Investments Ltd acquired 1,20,58,525 equity shares representing 3.24% stake in IIFL Capital Services Limited through an open offer completed on November 18, 2026. This acquisition boosted their total shareholding to 41.28%, making them the promoter of IIFL Capital Services as of November 19, 2026.
Read Full StoryICICI Prudential AMC Secures SEBI Approval to Acquire PMS Business from ICICI Securities
ICICI Prudential Asset Management Company Limited announced receipt of SEBI's approval to acquire the Portfolio Management Services business from ICICI Securities Limited, allowing the progression of the slump sale transaction agreed earlier in 2026.
Read Full StoryLT Foods acquires MK Foods Holdings to strengthen US-ready-to-eat food portfolio with Maya Kaimal brand
LT Foods Limited’s subsidiary LT Foods Americas Inc. has signed a definitive agreement to acquire 100% of MK Foods Holdings, Inc., a US-based company known for its premium Indian-inspired brand Maya Kaimal. The acquisition, valued at USD 5.8 million on a cash-free, debt-free basis, is expected to be completed within three months, adding a strong ready-to-eat and ready-to-cook portfolio to LT Foods’ US presence.
Read Full Story